ARTICLE | Clinical News
OBE101: Phase II started
May 21, 2007 7:00 AM UTC
Obecure started a double-blind, placebo-controlled, Israeli Phase II trial in 30 patients to evaluate OBE101 in combination with Zocor simvastatin from Merck & Co. Inc. (MRK, Whitehouse Station, N.J...